-- Sunshine Lake Pharma (HKG:6887) said the Hong Kong Stock Exchange has granted listing approval for its Hong Kong share full circulation application, according to a Wednesday bourse filing.
Shares of the pharmaceutical firm were up nearly 1% in Thursday morning trade.
The approval covers the conversion of about 208.4 million domestic shares into Hong Kong-listed shares.
The converted shares represent about 36.1% of the company's total issued share capital.
Upon completion, Hong Kong-listed shares will account for about 55.7% of the company's total share capital, up from 19.6% before the conversion.